» Articles » PMID: 20498206

Excess Risk of Hospital Admission for Cardiovascular Disease Within the First 7 Years from Onset of Inflammatory Polyarthritis

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2010 May 26
PMID 20498206
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives:

Subjects: with rheumatoid factor positive inflammatory polyarthritis (IP) are known to have increased mortality from cardiovascular disease (CVD). A study was undertaken to examine the risk and baseline predictors of admission with CVD in patients with recent-onset IP.

Methods: Subjects are recruited by the Norfolk Arthritis Register if they present to primary or secondary care with > or =2 swollen joints lasting > or =4 weeks. This analysis includes subjects recruited between 1995 and 1999. Baseline data on lifestyle, demographic characteristics, disease and treatment characteristics were collected. CVD admissions were identified through record linkage with the only acute care hospital in the study region. First-episode hospitalisation rates were compared with those of the general population. Poisson regression was used to calculate the relative risk (RR) of admission for patients with IP (overall and for each risk factor). Death certificates were obtained from the national death register.

Results: 800 patients with recent-onset IP were followed for a median of 7.0 years. 64 CVD-related hospitalisations were observed (11.7 per 1000 person-years). Patients with IP were twice as likely (RR=2.0; 95% CI 1.5 to 2.5) to be hospitalised for CVD as the general population. Difficulty walking at baseline was a significant predictor of CVD admission and baseline non-steroidal anti-inflammatory drug use was associated with a reduced risk of CVD admission.

Conclusions: Patients with IP are at increased risk of CVD-related hospitalisation, within 7 years of symptom onset. Informing patients about lifestyle modification may reduce the risk of CVD.

Citing Articles

We should not avoid diclofenac in the treatment of spondyloarthritis.

Zingler G, Herdegen T Ann Transl Med. 2019; 6(Suppl 1):S36.

PMID: 30613611 PMC: 6291570. DOI: 10.21037/atm.2018.09.42.


Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy.

Udachkina H, Novikova D, Popkova T, Kirillova I, Markelova E, Luchikhina E Rheumatol Int. 2017; 38(2):211-217.

PMID: 29079928 DOI: 10.1007/s00296-017-3860-9.


Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Ruscitti P, Margiotta D, Macaluso F, Iacono D, DOnofrio F, Emmi G Medicine (Baltimore). 2017; 96(42):e8180.

PMID: 29049200 PMC: 5662366. DOI: 10.1097/MD.0000000000008180.


Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study.

Ruscitti P, Cipriani P, Masedu F, Romano S, Berardicurti O, Liakouli V PLoS One. 2017; 12(1):e0170108.

PMID: 28103312 PMC: 5245879. DOI: 10.1371/journal.pone.0170108.


Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial.

Svensson A, Christensen R, Persson F, Logstrup B, Giraldi A, Graugaard C BMJ Open. 2016; 6(4):e009134.

PMID: 27098820 PMC: 4838680. DOI: 10.1136/bmjopen-2015-009134.


References
1.
Goodson N, Brookhart A, Symmons D, Silman A, Solomon D . Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. Ann Rheum Dis. 2008; 68(3):367-72. PMC: 2633631. DOI: 10.1136/ard.2007.076760. View

2.
Avina-Zubieta J, Choi H, Sadatsafavi M, Etminan M, Esdaile J, Lacaille D . Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008; 59(12):1690-7. DOI: 10.1002/art.24092. View

3.
Bursi F, Weston S, Killian J, Gabriel S, Jacobsen S, Roger V . C-reactive protein and heart failure after myocardial infarction in the community. Am J Med. 2007; 120(7):616-22. DOI: 10.1016/j.amjmed.2006.07.039. View

4.
Kremers H, Crowson C, Therneau T, Roger V, Gabriel S . High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum. 2008; 58(8):2268-74. PMC: 2929699. DOI: 10.1002/art.23650. View

5.
MacGregor A, Bamber S, Silman A . A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of an analysis from a nationwide twin study. J Rheumatol. 1994; 21(8):1420-6. View